Cadalimab (adalimumab biosimilar) / Cadila  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cadalimab (adalimumab biosimilar) / Cadila
adalimumabZydCad: A study to evaluate efficacy, tolerability and safety of Adalimumab (Zydus) and Adalimumab (Reference) in patients with Rheumatoid Arthritis

Not yet recruiting
3
120
RoW
adalimumab biosimilar
Cadila Healthcare Limited
 
 

Download Options